Both SCSE and Sch B significantly improved skin barrier function in AD mice, as evidenced by reduced transepidermal water loss (TEWL) and upregulation of key barrier proteins (Filaggrin, Loricrin, and Claudin-1). Here, LORICRIN is linked to Alzheimer disease.